BUNGE LIMITED (NYSE: BG) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Item 5.02

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On December 5, 2018, the Board of Directors (the "Board") of Bunge Limited (the “Company”) appointed J. Erik Fyrwald as a director of the Company. Mr. Fyrwald was appointed to the Board in accordance with the Cooperation Agreement, dated October 31, 2018, among theCompany, Continental Grain Company and Mr. Paul Fribourg, and the separate Cooperation Agreement, dated as of October 31, 2018, with D. E. Shaw Valence Portfolios, L.L.C. and D. E. Shaw Oculus Portfolios, L.L.C. (collectively, the “Cooperation Agreements”), to which an additional mutually agreed independent director would be appointed to the Board.

Mr. Fyrwald was appointed to the Audit Committee and the Finance and Risk Policy Committee of the Board. Mr. Fyrwald will be entitled to the same compensation, indemnification and other benefits as the Company’s other non-employee directors. Mr. Fyrwald is the Chief Executive Officer of Syngenta International AG (“Syngenta”). From time to time over the past three years, the Company has engaged in ordinary course commercial transactions with Syngenta. These transactions represented less than0.1% of the Company’s consolidated revenues in each year.

The foregoing references to the Cooperation Agreements do not purport to be complete and are qualified in their entirety by reference to the full text of the Cooperation Agreements, copies of which are filed as Exhibits 10.01 and 10.2 to the Company's Current Report on Form8-Kfiled with the Securities and Exchange Commission on October 31, 2018.

Item 7.01Regulation FD Disclosure.

A copy of the press release issued by the Company on December 5, 2018relating to Mr. Fyrwald's appointment to the Board is furnished herewith asExhibit 99.1and incorporated herein by reference.

Item 9.01Financial Statements and Exhibits.

(d)Exhibits.

Bunge LTD Exhibit
EX-99.1 2 pressrelease-fyrwaldfinal.htm EXHIBIT 99.1 Exhibit                                 Investor Contact:Mark Haden Bunge Limited 914-684-3398 [email protected]  Media Contact:Bunge News Bureau Bunge Limited 914-684-3246 [email protected]. Erik Fyrwald to Join Bunge Limited Board of DirectorsWHITE PLAINS,…
To view the full exhibit click here